The Molecular Diagnostics industry is witnessing huge demand and anticipates continued growth in the coming years due to rising infectious diseases and their diagnosis. Moreover, the rise in the incidence and prevalence of disease and growing demand for technologically advanced point-of-care diagnostics platforms, among others, are expected to fuel the overall Molecular Diagnostics market globally.
Furthermore, there has been a significant upsurge in R&D efforts and research studies, contributing significantly to industry expansion. These studies have offered a deep insight to the healthcare industry to facilitate a better understanding of human health and develop care standards for diagnosing diseases.
Discover the vital role Molecular Diagnostics plays in a wide range of disease detection and public health in our webinar hosted by Alveo in partnership with Omnia Health. Meet our esteemed panel of global medical laboratory experts, including Dr. Dana Welle DO JD, Marwan Abdulaziz Janahi, Ray Sinnott, Dr. Robert Patel and Alveo’s very own Mary McFillin, Sr. Director of Product Management who highlight the importance of getting access to real-time test results and how it will transform healthcare.